News – Hervolution

News

MGT_JR_Coleman

News Press

HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

19 Dec 2023

By Hervolution

Robert Langer

News

HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board

13 Sep 2023

By Hervolution

pexels-photo-3786247

News

New Research Reveals the Crucial Role of Endogenous Retrovirus Immunity in Tumor Immunity and Vaccine Development

09 Jun 2023

By Hervolution

971c7d753c56304e_800x800ar

News

Hervolution announces EUR 6M Seed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy

24 May 2023

By Hervolution

flight-sky-earth-space

Funding

Hervolution has been awarded an EU grant to further explore the role of IPT001 in oncological immunotherapy approaches against hard to treat cancers

16 Dec 2022

By Hervolution

pexels-photo-3938022

Funding

Hervolution receives 2.5M EUR in funding through the European Innovation Council Accelerator

15 Oct 2021

By Hervolution

_DSC2407final

News

Dr. Martin Gleave joins Hervolution as scientific advisor

23 Nov 2020

By Hervolution

Hervolution_Sharon_Glynn

News

Postdoctoral grant allows Hervolution to engage in new exciting collaborations

30 Oct 2020

By Hervolution

inprotherblogpost

News

Hervolution attracts profile from NIH: Emeline Ragonnaud reunites with Peter J. Holst after 3 years

19 Jun 2020

By Hervolution

inprotherblog

News

A family of research superstars: Hervolution’s founder is carrying on an impressive legacy

13 Mar 2020

By Hervolution

bloginprotherpost

News

CEO at SIRION, Christian Thirion, joins Hervolution as a Board Member

02 Mar 2020

By Hervolution

inprother-blogpost

News

Former F-star CEO joins Hervolution as strategic advisor

17 Feb 2020

By Hervolution

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, Hervolution for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)

News

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, Hervolution for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)

05 Feb 2020

By Hervolution

biotech

News

Hervolution will be presenting at Biotech Showcase 2020

03 Dec 2019

By Hervolution

DEMODAY

News

Hervolution pitch at Novo BII demo-day by Peter J. Holst

24 Jun 2019

By Hervolution

STEVENGLAZER

News

Steven Glazer joins Hervolution as Medical Advisor

24 Jun 2019

By Hervolution

peter-johannes-holst

News

Hervolution presentation by Peter J. Holst

13 May 2019

By Hervolution

Blog_post_2

News

Hervolution receives investment from Novo Nordisk Foundation

15 Feb 2019

By Hervolution

Hervolution ApS
Novo Nordisk BioInnovation Institute COBIS
CVR: 33968426
Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark
Copyright 2023 ©

Privacy Policy | Legal Advice

Hervolution ApS
Novo Nordisk
BioInnovation Institute COBIS
CVR: 33968426
Ole Maaløes Vej 3,
2200 Copenhagen N,
Denmark
Copyright 2023 ©

Privacy Policy | Legal Advice